Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicinagl
dc.contributor.authorFernández Álvarez, Iria
dc.contributor.authorZapata Cachafeiro, Maruxa
dc.contributor.authorVázquez Lago, Juan M.
dc.contributor.authorLópez Vázquez, Paula María
dc.contributor.authorPiñeiro Lamas, María
dc.contributor.authorGarcía Rodríguez, Raquel
dc.contributor.authorFigueiras Guzmán, Adolfo
dc.contributor.authorGREPHEPI Group
dc.date.accessioned2020-04-20T11:19:11Z
dc.date.available2020-04-20T11:19:11Z
dc.date.issued2019
dc.description.abstractObjectives : To assess the impact of sources of drug information on antibiotic prescribing patterns (quantity and quality) among primary care physicians. Methods : We conducted a cohort study on primary care physicians who were actively engaged in medical practice in 2010 in a region in north-west Spain (Galicia), fulfilling inclusion criteria (n = 2100). As the independent variable, we took the perceived utility of 6 sources of information on antibiotics, as measured by the validated KAAR-11 questionnaire. As dependent variables, we used: (1) a quality indicator (appropriate quality, defined as any case where 6 of the 12 indicators proposed by the European Surveillance of Antimicrobial Consumption Network [ESAC-Net] were better than the mean values for Spain); and, (2) a quantity indicator (high prescribing), defined as any case where defined daily doses (DDD) per 1 000 inhabitants per day of antibacterials for systemic use were higher than the mean values for Spain. The adjusted odds ratio for a change in the interquartile range (IqOR) for each sources of information on antibiotics was calculated using Generalized Linear Mixed Models. Results : The questionnaire response rate was 68%. Greater perceived utility of pharmaceutical sales representatives increases the risk of having high prescribing (1/IqOR = 2.50 [95%CI: 1.63–3.66]) and reduces the probability of having appropriate quality (1/IqOR = 2.28 [95%CI: 1.77–3.01]). Greater perceived utility of clinical guidelines increases the probability of having appropriate quality (1/IqOR = 1.25 [95%CI: 1.02–1.54]) and reduces the probability of high prescribing (1/IqOR = 1.25 [95%CI: 1.02–1.54]). Conclusions : Sources of information on antibiotics are an important determinant of the quantity and quality of antibiotic prescribing in primary care. Commercial sources of information influence prescribing negatively, and clinical guidelines are associated with better indicators.gl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was supported in part by the Instituto de Salud Carlos III (PI081239, PI09/90609) Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016, The European Regional Development Fund (ERDF) and the Mutua Madrileña insurance companygl
dc.identifier.citationFernandez-Alvarez, I., Zapata-Cachafeiro, M., Vazquez-Lago, J., Lopez-Vazquez, P., Pineiro-Lamas, M., Garcia Rodriguez, R., & Figueiras, A. (2019). Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in spanish primary care. PLoS ONE, 14(8) doi:10.1371/journal.pone.0221326gl
dc.identifier.doi10.1371/journal.pone.0221326
dc.identifier.essn1932-6203
dc.identifier.urihttp://hdl.handle.net/10347/21544
dc.language.isoenggl
dc.publisherPLOSgl
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0221326gl
dc.rights© 2019 Fernández-Álvarez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.gl
dc.rights.accessRightsopen accessgl
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titlePharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary caregl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication0b322a46-7514-4e0e-a63d-fa420104246f
relation.isAuthorOfPublicationfdc2ac91-bdd5-45cc-859d-e133bbec7d73
relation.isAuthorOfPublication72c1b02b-5726-4b24-84a4-481e1591b6b5
relation.isAuthorOfPublication.latestForDiscovery0b322a46-7514-4e0e-a63d-fa420104246f

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019_pone_fernandez_phramaceutical.pdf
Size:
575.99 KB
Format:
Adobe Portable Document Format
Description: